Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Omega-3 Use Grows Despite Doubts, Herbals Rise Above NY Controversy

This article was originally published in The Tan Sheet

Executive Summary

The Council for Responsible Nutrition’s 16th annual survey shows questions raised by researchers, state officials and media about the safety and efficacy of some supplement ingredients do not appear to slowing users’ interest in the products.

You may also be interested in...



MJN Sales, CRN Survey: Health And Wellness News Roundup

Foreign exchange slows Mead Johnson; import alerts for spiked supplements climb; and supplement use grows among younger adults.

Researchers Suggest Supplement Sales Grow As Consumers Ignore Studies

US adults' use of vitamins and supplements remained at around 52% from 1999 through 2012, information that should point lawmakers to ensuring more information is made known to consumers about studies questioning the products’ benefit, researchers say a JAMA study and editorial.

AREDS-Inspired Study Challenges Omega-3 Cognitive Benefit Claims

Omega-3 supplementation had no impact on cognitive function in a five-year assessment of elderly people participating in AREDS2 research, say NIH researchers. But they add in the JAMA study that longer-term use of omega-3s could result in a different outcome.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107986

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel